NM_000268.4(NF2):c.1726A>T (p.Thr576Ser) AND Hereditary cancer-predisposing syndrome

Clinical significance:Uncertain significance (Last evaluated: Jan 21, 2019)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV001012906.1

Allele description [Variation Report for NM_000268.4(NF2):c.1726A>T (p.Thr576Ser)]

NM_000268.4(NF2):c.1726A>T (p.Thr576Ser)

Gene:
NF2:NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q12.2
Genomic location:
Preferred name:
NM_000268.4(NF2):c.1726A>T (p.Thr576Ser)
HGVS:
  • NC_000022.11:g.29681590A>T
  • NG_009057.1:g.83035A>T
  • NM_000268.4:c.1726A>TMANE SELECT
  • NM_016418.5:c.1726A>T
  • NM_181825.3:c.1726A>T
  • NM_181828.3:c.1600A>T
  • NM_181829.3:c.1603A>T
  • NM_181830.3:c.1477A>T
  • NM_181831.3:c.1477A>T
  • NM_181832.3:c.1726A>T
  • NM_181833.3:c.448-13162A>T
  • NP_000259.1:p.Thr576Ser
  • NP_057502.2:p.Thr576Ser
  • NP_861546.1:p.Thr576Ser
  • NP_861966.1:p.Thr534Ser
  • NP_861967.1:p.Thr535Ser
  • NP_861968.1:p.Thr493Ser
  • NP_861969.1:p.Thr493Ser
  • NP_861970.1:p.Thr576Ser
  • LRG_511t1:c.1726A>T
  • LRG_511t2:c.1726A>T
  • LRG_511:g.83035A>T
  • LRG_511p2:p.Thr576Ser
  • NC_000022.10:g.30077579A>T
  • NM_000268.3:c.1726A>T
  • NR_156186.2:n.2208A>T
Protein change:
T493S
Links:
dbSNP: rs1601666549
NCBI 1000 Genomes Browser:
rs1601666549
Molecular consequence:
  • NM_181833.3:c.448-13162A>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000268.4:c.1726A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_016418.5:c.1726A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181825.3:c.1726A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181828.3:c.1600A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181829.3:c.1603A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181830.3:c.1477A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181831.3:c.1477A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181832.3:c.1726A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_156186.2:n.2208A>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001173424Ambry Geneticscriteria provided, single submitter
Uncertain significance
(Jan 21, 2019)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Details of each submission

From Ambry Genetics, SCV001173424.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

The p.T576S variant (also known as c.1726A>T), located in coding exon 15 of the NF2 gene, results from an A to T substitution at nucleotide position 1726. The threonine at codon 576 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved through mammals but not in all available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: Nov 27, 2021

Support Center